S&P 500 7,773.95 +0.66%
Nasdaq 27,477.31 +1.05%
S&P/TSX 35,518.55 +0.04%
Apple 332.89 −0.24%
Nvidia 238.90 +2.12%
Microsoft 525.18 +1.48%
Shopify 228.17 +5.70%
Royal Bank 277.59 −0.47%
CAD/USD 0.7010 −0.08%
CLOSED · 01:05 ET
Market ClerkRecap
Tue Oct 6 · markets closed1 signal on Oct 5224 insider buys this week · $10330.4BCIRO short report next: Oct 14The week ahead
EM
INSIDER · ROIV · Roivant Sciences Ltd. · DIRECTOR

Epperly Melissa B,

Every open-market transaction filed under this name, Sep 15 to Oct 1.

Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$837K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 1ROIVRoivant Sciences Ltd.DirectorSell900$36.57$33K−2.2%
Oct 1ROIVRoivant Sciences Ltd.DirectorSell16,850$36.08$608K−0.8%
Sep 15ROIVRoivant Sciences Ltd.DirectorSell600$40.38$24K−11.4%
Sep 15ROIVRoivant Sciences Ltd.DirectorSell4,338$39.65$172K−9.8%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.